Endocannabinoid System Research: Cannabinoids in Pediatric Care
Cannabinoid clinical trials pediatric care research is evolving with growing evidence on safety and efficacy in children. Most current data come from observational studies and surveys. Clinicians should interpret findings cautiously while monitoring…
Cannabis and Schizophrenia: Meta-Analysis Finds Roughly Threefold Risk Elevation, but Causation Remains Contested
The cannabis schizophrenia risk meta-analysis reveals a significant association between cannabis use and increased schizophrenia risk. This risk is especially pronounced with adolescent use and high-THC products. However, causation remains contested due…
Cannabinoids for Pediatric Care: Clinical Evidence Review
The cannabinoids clinical evidence pediatric data primarily comes from observational studies rather than controlled trials. This limits the strength of conclusions about safety and efficacy in children. Ongoing research continues to update the clinical…
Endocannabinoid System Research: Cannabis Use in Pregnancy
Maternal cannabis use in pregnancy is linked to a modestly elevated risk of autism spectrum disorder and ADHD in children. This association is supported by pooled data from multiple observational studies. Current evidence advises caution due to potential…